BEAM, BOL, KERA, LASE, LCAV, LVCI, LZRC, VISX, SNRS, STAA Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BEAM, BOL, KERA, LASE, LCAV, LVCI, LZRC, VISX, SNRS, STAA

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Alan A. Hicks who wrote (149)	7/11/1999 1:28:00 PM
From: Charles Rouah	Read Replies (2) of 253

Alan: What are the numbers on STAA's ICL sales and KERA's Intacs? I do know that Intacs cost the surgeon about 5 times the price as ICL's, so they wouldn't necessarily have to sell more to make more. Also, are ICL's approved by the FDA? Charles

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next